Truist Financial Corp Abcam PLC Transaction History

Truist Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$12.62 - $24.47 $153,320 - $297,286	-12,149 Reduced 28.14%	31,026 $759,000
Q1 2023 May 05, 2023	BUY	$12.98 - $17.1 $60,759 - $80,045	4,681 Added 12.16%	43,175 $581,000
Q4 2022 Feb 17, 2023	BUY	$13.92 - $17.0 $9,284 - $11,339	667 Added 1.76%	38,494 $598,000
Q3 2022 Oct 26, 2022	BUY	$13.36 - $16.75 $150,206 - $188,320	11,243 Added 42.29%	37,827 $567,000
Q2 2022 Jul 22, 2022	BUY	$12.69 - $19.25 $106,925 - $162,200	8,426 Added 46.4%	26,584 $384,000
Q1 2022 Apr 22, 2022	BUY	$15.5 - $23.89 $281,449 - $433,794	18,158 New	18,158 $332,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.